Dazan
(E)-1-N'-[2-[[5-[(Dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 3001055.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmacare limited û woodmead1 of 2 cancelled | Dazan | 150, 300 | 310031, 310032 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dazan effervescent 150 EACH TABLET CONTAINS RANITIDINE HYDROCHLORIDE EQUIVALENT TO RANITIDINE 150 mg | 150Effervescent | 31003131/11.4.3/0031 | Cancelled | Not determined | None |
| Dazan effervescent 300 EACH TABLET CONTAINS RANITIDINE HYDROCHLORIDE EQUIVALENT TO RANITIDINE 300 mg | 300Effervescent | 31003231/11.4.3/0032 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Ranitidine
- except where administered orally for short-term symptomatic relief of heartburn and hyperacidity, subject to a maximum dose of 75 milligrams, a maximum daily dose of 300 milligrams and a maximum treatment period of two weeks. (S2)
Consolidated Schedules 06 July 2026, lines 4205 to 4207
S2: Ranitidine
- when administered orally for short-term symptomatic relief of heartburn and hyperacidity, subject to -
- a maximum dose of 75 milligrams;
- a maximum daily dose of 300 milligrams;
- a maximum treatment period of two weeks. (S3)
Consolidated Schedules 06 July 2026, lines 2625 to 2632
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.